BOOSTING ONCOLOGY INVESTIGATION WITH INTEGRATED KRAS ASSAY PROVIDERS AND RAS ASSAYS

within the fast evolving discipline of oncology investigate, accurate and efficient mutation screening is vital for establishing focused therapies. The KRAS companies System performs a pivotal position Within this landscape by offering extensive methods for KRAS mutation profiling and Examination. KRAS mutations, present in about ninety five% of RA